… pain. We investigated the functional change of TRPV1 in OA pain using a mono-iodoacetate
(MIA) induced joint pain … resulting in joint degeneration and cartilage loss with joint pain in …

… MIA model may be useful for investigating chronic nociceptive pain 10 , 11 , 12 . In this study…
MIA in the knee joints. The severity of MIA-induced joint pain was measured by assessment …

… in patellar cartilage, as measured by Na,”S04 incorporation after intraarticular injection of
various doses of mono-iodoacetate (MIA) in the right knee joint of rats. A, 3.0 mg. B, 0.3 mg. …

… Intra-articular injection of monosodium iodoacetate (MIA) in the knee joint of rats disrupts …
as a model of osteoarthritis (OA) pain. Central sensitization through activation of mitogen …

… It is defined clinically by joint pain, deformity, and loss of function and pathologically by …
Figure 1 Histopathological progression in the monosodium iodoacetate model of osteoarthritis. …

… is a common clinical problem for which both inflammatory and degenerative joint diseases …
joint pain. The murine model of monosodium iodoacetate (MIA) was used to induce joint pain …

… (OA) pain induction, intra-articular mono-iodoacetate (MIA) injection … Herein, we aimed to
compare the pain intensity of rats … the development of pain behaviour and joint pathology in a …

… pain are major symptoms of joint disease, motivating the development of methods to quantify
motor behaviour in rodent joint pain … evaluation after induction of rat monoiodoacetate (MIA) …

… of pain and joint destruction. OA is characterized by a progressive degeneration of articular
cartilage [4, 5]. Increases of mechanical stress and biochemical factors in the affected joints …

… Osteoarthritis (OA), a chronic degenerative joint disease, will affect an increasing number of
… knee osteoarthritis pain induced by intra-articular injection of monosodium iodoacetate, an …